An Open-label, Randomized, 2-Period Crossover Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose Pharmacokinetics of Danicamtiv in Healthy Participants
Latest Information Update: 12 Aug 2022
At a glance
- Drugs Danicamtiv (Primary) ; Diltiazem (Primary) ; Itraconazole (Primary)
- Indications Dilated cardiomyopathy
- Focus Pharmacokinetics
- 09 Aug 2022 Status changed from recruiting to completed.
- 11 Jan 2022 Planned number of patients changed from 30 to 24.
- 11 Jan 2022 Status changed from not yet recruiting to recruiting.